ヒスイ ドレディアVSTAR (Holofoil)
Hisuian Lilligant VSTAR
タイムゲイザー
Time Gazer · #80
Overview
Legality, special rules, and flavor text
Format legality
- StandardNot Legal
- UnlimitedLegal
- ExpandedLegal
- Gym Leader ChallengeLegal
Rules
ポケモンVSTARがきぜつしたとき、相手はサイドを2枚とる。
Card details
Printing, type line, and catalog data
Identity & printing
- Card ID
- swsh10d_ja-80--holofoil
- Name
- ヒスイ ドレディアVSTAR (Holofoil)
Hisuian Lilligant VSTAR - Number
- 80
- Printed number
- 080/067
- Rarity
- ハイパーレア
Hyper Rare - Rarity code
- HR
- Variant
- Holofoil
Type line & stats
- Supertype
- ポケモン
Pokémon - Subtypes
- VSTAR
- Types
- 草
Grass - HP
- 260
- Evolves from
- ヒスイ ドレディアV
Hisuian Lilligant V
Set, artist & references
- Retreat cost
- 1
Colorless - Artist
- 5ban Graphics
- Regulation mark
- F
- Language
- Japanese
- Set name
- タイムゲイザー
Time Gazer - Game name
- Pokémon Japan
Battle
Abilities, attacks, weakness & resistance
Abilities
- 特性: スターパフューム
Star Perfume自分の番に使える。自分の山札からGrassエネルギーを合計5枚まで選び、相手に見せて、手札に加える。そして山札を切る。［対戦中、自分はVSTARパワーを1回しか使えない。］
During your turn, you may search your deck for up to 5 in any combination of Grass Pokémon and Grass Energy cards, reveal them, and put them into your hand. Then, shuffle your deck. (You can't use more than 1 VSTAR Power in a game.)
Attacks
- キャメルスピン
Camel Spin130+Cost: 3のぞむなら、このポケモンについているエネルギーを1個選び、手札にもどす。その場合、100ダメージ追加。
You may put an Energy attached to this Pokémon into your hand. If you do, this attack does 100 more damage.
Weaknesses
- 炎
Fire ×2
eBay market prices
Sold and listed medians — tap a grade for comps
More conditions (eBay)
Add LP / MP / HP / DMG or a slab grade (PSA 8, ACE 9, BGS 9.5, …). Everyone sees the same prices; scheduled refreshes include these variants.
Listed on marketplace
Vendors currently listing this card/product on our marketplace. Click through to view or purchase (purchase flow coming soon).
No marketplace listings for this card right now.
More in this set
Other cards from Time Gazer
Comments
Share your thoughts on this card — condition, value, pull rates, etc.
to comment.
No comments yet. Be the first to share your thoughts.